Skip to main content

Advertisement

Log in

Prognostic Significance and Management of Sentinel Nodes in the Triangular Intermuscular Space of Patients with Melanoma

  • Melanoma
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

The clinical significance of sentinel nodes (SNs) in the triangular intermuscular space (TIS) of patients with melanoma is poorly understood. This study aimed to determine their incidence and positivity rate, and to report their management and patient outcomes.

Methods

This was a single-institution retrospective cohort study of patients with unilateral or bilateral TIS SNs on lymphoscintigraphy treated between 1992 and 2017. Recurrence-free survival was analyzed.

Results

Lymphoscintigraphy identified TIS SNs in 266 patients. They were bilateral in 17 patients. Of the 2296 patients with a melanoma on the upper back, 259 (11%) had TIS SNs. Procurement of SNs was not attempted in 122 (43%) of the 283 cases and failed in 11 cases (7%). An SN was successfully retrieved from the TIS in 145 patients (53%) and contained metastasis in 18 of 150 TIS SNs. This was the only positive SN in 12 patients (8%), upstaging all of them. Of the 18 patients with a positive SN in the TIS, 9 (50%) underwent completion axillary lymph node dissection, but no additional involved nodes were found in any of these patients. Recurrence in the TIS was observed in six patients (5%), none of whom had their TIS SN surgically pursued previously.

Conclusions

Lymphoscintigraphy showed TIS SNs in 11% of patients with melanomas on their upper back. In such cases, retrieval of TIS SNs is required for accurate staging and to minimize the risk of TIS recurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Balch CM, Gershenwald JE. Clinical value of the sentinel-node biopsy in primary cutaneous melanoma. N Engl J Med. 2014;370:663–4.

    Article  CAS  PubMed  Google Scholar 

  2. Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 1999;17:976–83.

    Article  CAS  PubMed  Google Scholar 

  3. Jansen L, Nieweg OE, Peterse JL, Hoefnagel CA, Valdés Olmos RA, Kroon BBR. Reliability of sentinel lymph node biopsy for staging melanoma. Br J Surg. 2000;87:484–9.

    Article  CAS  PubMed  Google Scholar 

  4. Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370:599–609.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Faries MB, Cochran AJ, Thompson JF. Melanoma sentinel-node metastasis. N Engl J Med. 2017;377:892.

    PubMed  Google Scholar 

  6. Leiter U, Stadler R, Mauch C, et al. Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial. Lancet Oncol. 2016;17:757–67.

    Article  PubMed  Google Scholar 

  7. Long GV, Hauschild A, Santinami M, et al. Adjuvant dabrafenib plus trametinib in stage III BRAF-mutated melanoma. N Engl J Med. 2017;377:1813–23.

    Article  CAS  PubMed  Google Scholar 

  8. Weber J, Mandala M, Del Vecchio M, et al. Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma. N Engl J Med. 2017;377:1824–35.

    Article  CAS  PubMed  Google Scholar 

  9. Uren RF, Howman-Giles R, Thompson JF. Patterns of lymphatic drainage from the skin in patients with melanoma. J Nucl Med. 2003;44:570–82.

    PubMed  Google Scholar 

  10. Kaneko Y, Asai J, Wada M, et al. The triangular intermuscular space: an uncommon sentinel node location in melanoma of the upper arm. J Dermatol. 2015;42:548–50.

    Article  PubMed  Google Scholar 

  11. Uren RF, Howman-Giles R, Thompson JF, et al. Lymphatic drainage to triangular intermuscular space lymph nodes in melanoma on the back. J Nucl Med. 1996;37:964–6.

    CAS  PubMed  Google Scholar 

  12. Caracò C, Marone U, Di Monta G, et al. Surgical management of sentinel lymph node biopsy outside major nodal basin in patients with cutaneous melanoma. Ann Surg Oncol. 2014;21:300–5.

    Article  PubMed  Google Scholar 

  13. Roozendaal GK, de Vries JD, van Poll D, et al. Sentinel nodes outside lymph node basins in patients with melanoma. Br J Surg. 2001;88:305–8.

    Article  CAS  PubMed  Google Scholar 

  14. Estourgie SH, Nieweg OE, Valdés Olmos RA, Hoefnagel CA, Kroon BBR. Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years. Ann Surg Oncol. 2003;10:681–8.

    Article  PubMed  Google Scholar 

  15. Hennessy SA, Dengel LT, Hranjec T, Slingluff CL Jr. A triangular intermuscular space sentinel node in melanoma: association with axillary lymphatic drainage. Ann Surg Oncol. 2010;17:2465–70.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Herbert GS, Beshlian KM. The triangular intermuscular space as a site of lymph node metastasis in melanoma of the back. Ann Plast Surg. 2010;64:52–4.

    Article  CAS  PubMed  Google Scholar 

  17. Uren RF. Lymphatic drainage of the skin. Ann Surg Oncol. 2004;11:179S-S185.

    Article  PubMed  Google Scholar 

  18. Uren RF, Howman-Giles R, Chung D, Thompson JF. Nuclear medicine aspects of melanoma and breast lymphatic mapping. Semin Oncol. 2004;31:338–48.

    Article  PubMed  Google Scholar 

  19. Uren RF, Howman-Giles RB, Chung D, Thompson JF. Role of lymphoscintigraphy for selective sentinel lymphadenectomy. Cancer Treat Res. 2005;127:15–38.

    Article  PubMed  Google Scholar 

  20. Thompson JF, Uren RF. Lymphatic mapping in management of patients with primary cutaneous melanoma. Lancet Oncol. 2005;6:877–85.

    Article  PubMed  Google Scholar 

  21. Thompson JF, Uren RF, Shaw HM, et al. Location of sentinel lymph nodes in patients with cutaneous melanoma: new insights into lymphatic anatomy. J Am Coll Surg. 1999;189:195–204.

    Article  CAS  PubMed  Google Scholar 

  22. Nieweg OE, Tanis PJ, Kroon BBR. The definition of a sentinel node. Ann Surg Oncol. 2001;8:538–41.

    Article  CAS  PubMed  Google Scholar 

  23. Gershenwald JE, Scolyer RA, Hess KR, et al. Melanoma of the skin. AJCC Cancer Staging Manual. 2017;8:563–85.

    Article  Google Scholar 

  24. Li LX, Scolyer RA, Ka VS, et al. Pathologic review of negative sentinel lymph nodes in melanoma patients with regional recurrence: a clinicopathologic study of 1152 patients undergoing sentinel lymph node biopsy. Am J Surg Pathol. 2003;27:1197–202.

    Article  PubMed  Google Scholar 

  25. Nieweg OE, Jansen L, Kroon BBR. Technique of lymphatic mapping and sentinel node biopsy for melanoma. Eur J Surg Oncol. 1998;24:520–4.

    Article  CAS  PubMed  Google Scholar 

  26. Uren RF, Howman-Giles R, Chung D, Thompson JF. Guidelines for lymphoscintigraphy and F18 FDG PET scans in melanoma. J Surg Oncol. 2011;104:405–19.

    Article  PubMed  Google Scholar 

  27. Chakera AH, Hansen LB, Lock-Andersen J, Drzewiecki KT, Hesse B. In-transit sentinel nodes must be found: implication from a 10-year follow-up study in melanoma. Melanoma Res. 2008;18:359–64.

    Article  PubMed  Google Scholar 

  28. Nijhuis AA, Ivan Filho D, Uren RF, Thompson JF, Nieweg OE. Clinical importance and surgical management of sentinel lymph nodes in the popliteal fossa of melanoma patients. Eur J Surg Oncol. 2019;45(9):1706–11.

    Article  PubMed  Google Scholar 

  29. Ipenburg NA, Thompson JF, Uren RF, Chung D, Nieweg OE. Focused ultrasound surveillance of lymph nodes following lymphoscintigraphy without sentinel node biopsy: a useful and safe strategy in elderly or frail melanoma patients. Ann Surg Oncol. 2019;26:2855–63.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Ipenburg NA, Nieweg OE, Uren RF, Thompson JF. Outcome of melanoma patients who did not proceed to sentinel node biopsy after preoperative lymphoscintigraphy. Ann Surg Oncol. 2017;24:117–26.

    Article  PubMed  Google Scholar 

  31. Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307–17.

    Article  CAS  PubMed  Google Scholar 

  32. Crystal JS, Thompson JF, Hyngstrom J, et al. Therapeutic value of sentinel lymph node biopsy in patients with melanoma: a randomized clinical trial. JAMA Surg. 2022;157(9):835–42.

    PubMed  Google Scholar 

Download references

Acknowledgment

This study was funded by the Danish Cancer Society, Reinholdt W. Jorck og Hustrus Fond, and Knud Højgaard Fonden. We thank Melanoma Institute Australia and Alfred Nuclear Medicine and Ultrasound, Sydney, Australia for facilitating this study by providing staff assistance and resources. Special thanks go to Hazel Bourke, who undertook data extraction from the institutional database and to Kaye Oakley, Martin Drummond, and Kim Ioannou for their assistance.

Funding

Kræftens Bekæmpelse, Reinholdt W. Jorck og Hustrus Fond, Knud Højgaard Fonden, Melanoma Institute Australia.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John F. Thompson MD, FRACS, FACS.

Ethics declarations

Disclosures

John F. Thompson has received honoraria for advisory board participation from BMS Australia, MSD Australia, GSK, and Provectus Inc, as well as travel and conference support from GSK, Provectus Inc, and Novartis. Robyn P. M. Saw has received honoraria for advisory board participation from MSD, Novartis, and Qbiotics and speaking honoraria from BMS and Novartis. The remaining authors have no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schoenfeldt, T., Thompson, J.F., Lo, S. et al. Prognostic Significance and Management of Sentinel Nodes in the Triangular Intermuscular Space of Patients with Melanoma. Ann Surg Oncol 30, 2354–2361 (2023). https://doi.org/10.1245/s10434-022-12840-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-12840-2

Navigation